Advertisement

Patients With Multiple Myeloma Receiving Salvage Treatment After BCMA-Directed CAR T-Cell Therapy
Posted: 12/01/2022 | By: Sarah Campen, PharmD

A study published by Van Oekelen et al in Blood investigated salvage treatments for and outcomes among patients with multiple myeloma with disease progression after treatment with B-cell maturation antigen (BCMA)-directed chimeric antigen receptor (CAR) T-cell therapy.

Question 1 of 5

___ was the most common treatment type for the first line of salvage treatment following disease progression after BCMA-directed CAR T-cell therapy.

Choose 1

A
Autologous stem cell transplant
B
Selinexor-based therapy
C
T cell–directed therapy with bispecific antibodies
D
Combination chemotherapy

CategoriesView All Quizzes

Tumor Type


Additional Topics



Conference Coverage